Medication overuse headache

Bibliography

• HEADACHE CLASSIFICATION COMMITTEE OF THE INTERNATIONAL HEADACHE SOCIETY: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia (1988) 8(Suppl. 7):1-96.
   Web of Science ®Google Scholar
• OLESEN J, BOUSSER M-G, DIENER HC et al.: for the International Headache Society. The international classification of headache disorders, 2nd Edn. Cephalalgia (2004) 24(Suppl. 1):1-160.
   Web of Science ®Google Scholar
• MIHATSCH MJ: Das Analgetikasyndrom. New York: Thieme (1986).
   Google Scholar
• PETERS GA, HORTON BT: Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proceed. Staff Meet. Mayo. Clin. (1951) 26:153-161.
   PubMed Web of Science ®Google Scholar
• HORTON BT, PETERS GA: Clinical manifestations of excessive use of ergotamine preparations and management withdrawal effect: report of 52 cases. Headache (1963) 3:214-226.
   Google Scholar
• SCHWARZ A, FARBER U, GLAESKE G: Daten zu Analgetikakonsum und Analgetikanephropathie in der Bundesrepublik. Öffentliches Gesundheitswesen (1985) 47:298.
   PubMedGoogle Scholar
• GUTZWILLER F, ZEMP E: Der Analgetikakonsum in der Bevölkerung und sozioökonomische Aspekte des Analgetikaabusus. In: Mihatsch MJ (Ed) Das Analgetikasyndrom. Stuttgart, Thieme (1986):197.
   Google Scholar
• EGGEN AE: The Tromsø study: frequency and predicting factors of analgesic drug use in a free living population (12–56 years). J. Clin. Epidemiol. (1993) 46:1297-1304.
   PubMed Web of Science ®Google Scholar
• ZWART JA, DYB G, HAGEN K et al.: Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology (2003) 61:160-164.
   PubMed Web of Science ®Google Scholar
• LANTERI-MINET M, AURAY JP, EL HASNAOUI A: Prevalence and description of chronic daily headache in the general population of France. Pain (2003) 102:143-149.
   PubMed Web of Science ®Google Scholar
• CASTILLO J, MUNOZ P, GUITERA V, PASCUAL J: Epidemiology of chronic daily headache in the general population. Headache (1999) 39:190-196.
   PubMed Web of Science ®Google Scholar
• LU SR, FUH JL, CHEN WT, JUANG KD, WANG SJ: Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia (2001) 21:980-986.
   PubMed Web of Science ®Google Scholar
• PRENCIPE M, CASINI AR, FERRETTI C et al.: Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J. Neurol. Neurosurg. Psychiatry (2001) 70:377-381.
   PubMed Web of Science ®Google Scholar
• COLAS R, MUNOZ P, TEMPRANO R, GOMEZ C, PASCUAL J: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology (2004) 27:1338-1342.
   Google Scholar
• WANG SJ, FUH JL, LU SR et al.: Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology (2000) 54:314-319.
   PubMed Web of Science ®Google Scholar
• WANG S-J, FUH J-L, LU S-R, JUANG K-D: Chronic daily headache in adolescents. Prevalence, impact, and medication overuse. Neurology (Epub ahead of print).
   Google Scholar
• HERING-HANIT R, COHEN A, HOREV Z: Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache. J. Child. Neurol. (2001) 16:448-449.
   PubMed Web of Science ®Google Scholar
• SYMON DN: Twelve cases of analgesic headache. Arch. Dis. Child (1998) 78:555-556.
   PubMed Web of Science ®Google Scholar
• ROBINSON RG: Pain relief for headaches. Cam. Fam. Physician (1993) 39:867.
   PubMed Web of Science ®Google Scholar
• GRANELLA F, FARINA S, MALFERRARI G, MANZONI GC: Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia (1987) 7:15-19.
   PubMed Web of Science ®Google Scholar
• MICIELI G, MANZONI GC, GRANELLA F, MARTIGNONI E, MALFERRARI G, NAPPI G: Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M (Eds), Drug-induced Headache. New York: Springer (1988):20-28.
   Google Scholar
• CELENTANO DD, STEWART WF, LIPTON RB et al.: Medication use and disability among migraineurs: a national probability sample. Headache (1992) 32:223-228.
   PubMed Web of Science ®Google Scholar
• RAPOPORT A, WEEKS R, SHEFTELL F: Analgesic rebound headache: theoretical and practical implications. In: Olesen J, Tfelt-Hansen P, Jensen K (Eds). Proceedings of the Second International Headache Congress, Copenhagen, Denmark (1985):448-449.
   Google Scholar
• BAUMGARTNER C, WESSELY P, BINGOL C, MALY J, HOLZNER F: Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache (1989) 29:510-514.
   PubMed Web of Science ®Google Scholar
• MATHEW NT, KURMAN R, PEREZ F: Drug induced refractory headache – clinical features and management. Headache (1990) 30:634-638.
   PubMed Web of Science ®Google Scholar
• CATARCI T, FIACCO F, ARGENTINO C, SETTE G, CERBO R: Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia (1994) 14:374-375.
   PubMed Web of Science ®Google Scholar
• KAUBE H, MAY A, DIENER HC, PFAFFENRATH V: Sumatriptan misuse in daily chronic headache. Br. Med. J. (1994) 308:1573.
   PubMed Web of Science ®Google Scholar
• WILLIAMS D, CAHILL T, DOWSON A et al.: Usage of triptans among migraine patients: an audit in nine GP practices. Curr. Med. Res. Opin. (2002) 18:1-9.
   PubMed Web of Science ®Google Scholar
• GAIST D, ANDERSEN M, AARUP AL et al.: Use of sumatriptan in Denmark in 1994–5: an epidemiological analysis of nationwide prescription data. Br. J. Clin. Pharmacol. (1997) 43:429-433.
   PubMed Web of Science ®Google Scholar
• GAIST D, TSIROPOULUS I, SINDRUP SH et al.: Inappropriate use of sumatriptan: population based register and interview study. Br. Med. J. (1998) 316:1352-1353.
   PubMed Web of Science ®Google Scholar
• GAIST D, HALLAS J, SINDRUP SH, GRAM LF: Is overuse of sumatriptan a problem? A population-based study. Eur. J. Clin. Pharmacol. (1996) 50:161-165.
   PubMed Web of Science ®Google Scholar
• KATSARAVA Z, SCHNEEWEISS S, KURTH T et al.: Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology (2004) 62(5):788-790.
   PubMed Web of Science ®Google Scholar
• KATSARAVA Z, MUESSIG M. DZAGNIZA A, FRITSCHE G, DIENER HC, LIMMROTH V: Rate and predictors for relapses in medication overuse headache: a four year prospective study. Cephalalgia (2005) 25(1):12-15.
   PubMed Web of Science ®Google Scholar
• HAGEN K, VATTEN L, STOVNER LJ et al.: Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22 718 adults in Norway. Cephalalgia (2002) 22:672-679.
   PubMed Web of Science ®Google Scholar
• DIENER HC, DAHLOF CG: Headache associated with chronic use of substances. Olesen J, Tfelt-Hansen P, Welch KM (Eds),The headaches. 2nd Edn. Philadelphia: Lippincott, Williams & Wilkins (1999):871-878.
   Google Scholar
• LANCE F, PARKES C, WILKINSON M: Does analgesic abuse cause headache de novo? Headache (1988) 38:61-62.
   Google Scholar
• BAHRA A, WALSH M, MENON S, GOADSBY PJ: Does chronic daily headache arise de novo in association with regular analgesic use? Headache (2003) 43:179-190.
   PubMed Web of Science ®Google Scholar
• LIMMROTH V, KATSARAVA Z, FRITSCHE G, PRZYWARA S, DIENER HC: Features of medication overuse headache following overuse of different acute headache drugs. Neurology (2002) 59:1011-1014.
   PubMed Web of Science ®Google Scholar
• REUTER U, SALOMONE S, ICKSTEIN GW, WAEBER C: Effects of chronic sumatriptan and zolmitriptan treatment on 5-HAT receptor expression and function in rats. Cephalalgia (2004) 24:398-407.
   PubMed Web of Science ®Google Scholar
• SAUCIER C, MORRIS SJ, ALBERT PR: Endogenous serotonin-2A and -2C receptors in Balb/c-3T3 cells revealed in serotonin-free medium: desensitisation and down-regulation by serotonin. Biochem. Pharmacol. (1998) 56:1347-1357.
   PubMed Web of Science ®Google Scholar
• TOHYAMA Y, YAMANE F, FIKRE MERID M, BLIER P, DIKSIC M: Effects of serotonin receptor agonists, TFMPP and CGS12066B, on regional serotonin synthesis in the rat brain: an autoradiographic study. J. Neurochemistry (2002) 80:788-798.
   PubMed Web of Science ®Google Scholar
• DOBSON CF, TOHYAMA Y, DIKSIC M, HAMEL E: Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia (2004) 24:2-11.
   PubMed Web of Science ®Google Scholar
• SRIKIATKHACHORN A, ANTHONY M: Platelet serotonin in patients with analgesic-induced headache. Cephalalgia (1996) 16:423-426.
   PubMed Web of Science ®Google Scholar
• SRIKIATKHACHORN A, TARASUB N, GOVITRAPONG P: Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache (2000) 40:343-350.
   PubMed Web of Science ®Google Scholar
• GRIFFITHS RR, WOODSON PP: Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology (1988) 94:437-451.
   PubMed Web of Science ®Google Scholar
• GRIFFITHS RR, WOODSON PP: Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacol. Biochem. Behav. (1988) 29:419-427.
   PubMed Web of Science ®Google Scholar
• VAN DUSSELDORP M, KATAN MB: Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. Br. Med. J. (1990) 300:1558-1559.
   PubMed Web of Science ®Google Scholar
• SILVERMAN K, EVANS SM, STRAIN EC, GRIFFITHS RR: Withdrawal syndrome after the double-blind cessation of caffeine consumption. N. Engl. J. Med. (1992) 327:1109-1114.
   PubMed Web of Science ®Google Scholar
• ZIEGLER DK: Opiate and opioid use in patients with refractory headache. Cephalalgia (1994) 14:5-10.
   PubMed Web of Science ®Google Scholar
• FISHER MA, GLASS S: Butorphanol (Stadol): a study in problems of current drug information and control. Neurology (1997) 48:1156-1160.
   PubMed Web of Science ®Google Scholar
• SAPER JR, JONES JM: Ergotamine tartrate dependency: features and possible mechanisms. Clin. Neuropharmacol. (1986) 9:244-256.
   PubMed Web of Science ®Google Scholar
• FANCIULLACCI M, ALESSANDRI M, PIETRINI U, BRICCOLANI-BANDINI E, BEATRICE S: Long-term ergotamine abuse: effect on adrenergically induced mydriasis. Clin. Pharm. Ther. (1992) 51:302-307.
   PubMed Web of Science ®Google Scholar
• KRYMCHANTOWSKI AV, BARBOSA JS: Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia (2000) 20:107-113.
   PubMed Web of Science ®Google Scholar
• SMITH TR: Low-dose tizanidine with nonsteroidal anti-inflammatory drugs for detoxification from analgesic rebound headache. Headache (2002) 42:175-177.
   PubMed Web of Science ®Google Scholar
• DIENER H-C, HAAB J, PETERS C et al.: Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache (1990) 31:205-209.
   Web of Science ®Google Scholar
• WARNER JS: The outcome of treating patients with suspected rebound headache. Headache (2001), 41(7):685-692.
   PubMed Web of Science ®Google Scholar
• HERING R, STEINER TJ: Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet (1991) 337(8755):1442-1443.
   PubMed Web of Science ®Google Scholar
• HAAG G, BAAR H, GROTEMEYER KH et al.: Prophylaxe und Therapie des medikamenteninduzierten Dauerkopfschmerzes. Schmerz (1999) 13:52-57.
   PubMed Web of Science ®Google Scholar
• KATSARAVA Z, LIMMROTH V, FINKE M et al.: Rate and predictors for relapses in medication overuse headache: a one year prospective study. Neurology (2003) 60:1682-1684.
   PubMed Web of Science ®Google Scholar
• DIENER HC, DICHGANS J, SCHOLZ E, GEISELHART S, GERBER WD, BILLE A: Analgesic-induced chronic headache: long-term results of withdrawal therapy. J. Neurol. (1989) 236:9-14.
   PubMed Web of Science ®Google Scholar
• SCHNIDER P, AULL S, BAUMGARTNER C, MERTERER et al.: Long-term outcome of patients with headache and druf abuse after inpatient withdrawal: five year follow-up. Cephalalgia (1996) 16:481-485.
   PubMed Web of Science ®Google Scholar
• GRAZZI L, ANDRASIK F, D’AMICO D et al.: Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache (2002) 42:483-490.
   PubMed Web of Science ®Google Scholar
• EVERS S, SUHR B, BAUER B, GROTEMEYER KH, HUSSTEDT IW: A retrospective long-term analysis of the epidemiology and features of drug-induced headache. J. Neurol. (1999) 246:802-809.
   PubMed Web of Science ®Google Scholar
• PINI LA, CICERO AF, SANDRINI M: Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia (2001) 21:878-883.
   PubMed Web of Science ®Google Scholar
• TRIBL GG, SCHNIDER P, WOBER C et al.: Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia (2001) 21:691-696.
   PubMed Web of Science ®Google Scholar
• FRITSCHE G, EBERL A, KATSARAVA Z, LIMMROTH V, DIENER HC: Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur. Neurol. (2001) 45:229-235.
   PubMed Web of Science ®Google Scholar